“ROSSA” received a registration certificate for a new product – “ROSSAmed MBT screen” for detecting mycobacterial DNA using real-time PCR

The ROSSA Research and Production Complex is proud to announce that it has received a registration certificate for a new development – the “ROSSAmed MBT screen” PCR kit. This product is intended for the qualitative detection of DNA of mycobacteria from the Mycobacterium tuberculosis complex group (Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium africanum, Mycobacterium microti) using the polymerase chain reaction (PCR) method with real-time detection of results.

The “ROSSAmed MBT screen” is a highly effective and accurate tool for diagnosing mycobacterial infections. The kit uses advanced PCR technology to detect the presence of mycobacteria in patient samples with high sensitivity and specificity.

Obtaining a registration certificate for the “ROSSAmed MBT screen” kit is an important step in the fight against tuberculosis and other mycobacterial infections. The new development will help medical institutions timely and accurately diagnose the disease, which will facilitate early treatment and reduce the spread of infection.